<DOC>
	<DOC>NCT00736983</DOC>
	<brief_summary>To assess whether a combination of ciprofloxacin and adalimumab is more effective than adalimumab alone for the treatment of perianal fistulas in Crohn's disease</brief_summary>
	<brief_title>Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's</brief_title>
	<detailed_description>Dutch multicenter, randomized, double-blind study with two arms. 146 patients will be included.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>proven Crohn's disease Single or multiple draining perianal fistulas Abscesses Infliximab, cyclosporine, tacrolimus and antibiotics for Crohn's disease within past 3 months active viral infection significate cardiovascular dysfunction Pregnancy, Lactation Surgical bowel resection to be expected within 6 months Positive stool culture for enteric pathogens Total parental nutrition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Perianal fistulas</keyword>
	<keyword>Crohn's disease</keyword>
</DOC>